PsychoGenics Employee Directory
Research ServicesNew Jersey, United States51-200 Employees
PsychoGenics operates as a preclinical contract research organization with a focus on central nervous system and orphan disorders. It provides validated disease models and broad preclinical capabilities to help clients discover next-generation CNS therapies and reduce attrition in clinical development. The company emphasizes a translational approach and customized solutions, aiming to quantify treatment effects through phenotypic changes prior to clinical testing. Based in Paramus, New Jersey, PsychoGenics serves biopharmaceuticals of varying sizes with a portfolio of highly predictive mouse models, including in-licensed transgenic lines covering Alzheimer's disease, Huntington's disease, Parkinson's disease, autism spectrum disorders, psychosis and schizophrenia, spinal muscular atrophy, muscular dystrophy, and several pain conditions. Its work spans behavioral assessment and related preclinical evaluations, supporting clients in advancing candidates toward patient-focused outcomes. In 2023, the company launched eCube, an AI-enabled platform for drug discovery, reflecting its focus on translational data analysis.